Cocrystal Pharma, Inc. 8-K

What Happened

• Cocrystal Pharma, Inc. (COCP) filed a Current Report on Form 8‑K on March 31, 2026 reporting results of operations and financial condition. The filing states that on November 14, 2025 the company issued a press release announcing its results for the fiscal year ended December 31, 2025 and providing business updates. The press release is furnished as Exhibit 99.1 to the 8‑K.

Key Details

• Item reported: 2.02 (Results of Operations and Financial Condition).
• Filing date of this 8‑K: March 31, 2026.
• Period covered by the announcement: fiscal year ended December 31, 2025.
• Exhibit included: 99.1 — press release announcing the results and business updates.

Why It Matters

• This 8‑K signals that Cocrystal has publicly disclosed its FY2025 operating results and provided business updates to investors. The 8‑K itself furnishes the press release but does not replace filings that include audited financial statements (e.g., a Form 10‑K). Investors should review the Exhibit 99.1 press release and watch for the company’s annual report/10‑K for full financial detail and audited figures.